Skip to main content
  • Ticagrelor Plus Aspirin Lowers Risk of Adverse Limb Events in Patients with Diabetes, CAD, PAD

    Adding ticagrelor to aspirin for patients with diabetes, coronary artery disease (CAD) and peripheral artery disease (PAD) without a history of myocardial infarction (MI) or stroke lowers the risk of adverse limb events, according to study results presented Tuesday at the European Society of Cardiology (ESC) 2020 virtual congress.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details